Hyperhomocystinemia Impairs Endothelial Function and eNOS Activity via PKC Activation
- 1 December 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 25 (12) , 2515-2521
Abstract
Objective—A risk factor for cardiovascular disease, hyperhomocystinemia (HHcy), is associated with endothelial dysfunction. In this study, we examined the mechanistic role of HHcy in endothelial dysfunction.Methods and Results—Through the use of 2 functional models, aortic rings and intravital video microscopy of the cremaster, we found that arterial relaxation in response to the endothelium-dependent vessel relaxant, acetylcholine or the nitric oxide synthase (NOS) activator (A23187), was significantly impaired in cystathionine β-synthase null (CBS−/−) mice. However, the vascular smooth muscle cell (VSMC) response to the nitric oxide (NO) donor (SNAP) was preserved in CBS−/−mice. In addition, superoxide dismutase and catalase failed to restore endothelium-dependent vasodilatation. Endothelial nitric oxide synthase (eNOS) activity was significantly reduced in mouse aortic endothelial cells (MAECs) of CBS−/−mice, as well as in Hcy-treated mouse and human aortic endothelial cells (HAECs). Hcy-mediated eNOS inhibition—which was not rescued by adenoviral transduction of superoxide dismutase and glutathione peroxidase, or by tetrahydrobiopterin, sepiapterin, and arginine supplementations in MAEC—was associated with decreased protein expression and increased threonine 495 phosphorylation of eNOS in HAECs. Ultimately, a protein kinase C (PKC) inhibitor, GF109203X (GFX), reversed Hcy-mediated eNOS inactivation and threonine 495 phosphorylation in HAECs.Conclusions—These data suggest that HHcy impairs endothelial function and eNOS activity, primarily through PKC activation.Keywords
This publication has 35 references indexed in Scilit:
- Perturbations in homocysteine-linked redox homeostasis in a murine model for hyperhomocysteinemiaAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2004
- Mouse Cremaster Venules are Predisposed to Light/Dye‐Induced Thrombosis Independent of Wall Shear Rate, CD18, ICAM‐1, or P‐SelectinMicrocirculation, 2004
- Hyperhomocysteinemia accelerates atherosclerosis in cystathionine β-synthase and apolipoprotein E double knock-out mice with and without dietary perturbationBlood, 2003
- Increased Monocyte Adhesion to Aortic Endothelium in Rats With HyperhomocysteinemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- L-Arginine in cardiovascular disease: dream or reality?Vascular Medicine, 2002
- Adenovirus-mediated overexpression of extracellular superoxide dismutase improves endothelial dysfunction in a rat model of hypertensionGene Therapy, 2002
- Endothelial Dysfunction and Elevation of S -Adenosylhomocysteine in Cystathionine β-Synthase–Deficient MiceCirculation Research, 2001
- Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine modelJournal of Clinical Investigation, 2001
- Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemiaJournal of Clinical Investigation, 2000
- Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial DysfunctionCirculation, 1998